Come up with a name for your new list and we'll add to it:
Longevity Biotech raised a round of funding on , . Investors include
Wisconsin Alumni Research Foundation.
Longevity Biotech is developing a class of therapeutics via artificial protein technology (Hybridtides). Hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by nat…